NexPlasmaGen Incorporée
$50,000.00 CAD
≈ 8 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- April 2, 2018 – March 29, 2019
- Reference
- nrc-cnrc:172-2018-2019-Q1-905621
Published purpose
This project assesses a unique device as a potential adjuvant for breast cancer radiotherapy to enhance the selective kill of breast cancer cells in order to reduce cancer recurrence.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions